Alzheimer's Disease: Early Markers

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on early markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

August 7, 2020
Open Access

Biosynthesis and signalling functions of central and peripheral nervous system neurosteroids in health and disease

Essays in Biochemistry
Emyr Lloyd-Evans, Helen Waller-Evans
August 6, 2020
Open Access

Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions

Alzheimer's Research & Therapy
Unnur D TeitsdottirPetur H Petersen
August 6, 2020
Open Access

Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus

Frontiers in Aging Neuroscience
Yong-Xiang HeYing-Hua Liu
August 5, 2020

Benzimidazole based fluorophores for the detection of amyloid fibrils with higher sensitivity than Thioflavin-T

Journal of Neurochemistry
Narayanaperumal PravinMaheswaran Shanmugam
August 4, 2020

Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort

Journal of Alzheimer's Disease : JAD
Mari AksnesAnne-Brita Knapskog
August 4, 2020

Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease

Journal of Alzheimer's Disease : JAD
Audrey KelemanSusan L Stark
August 6, 2020
Open Access

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Sébastien BouloKaj Blennow
August 4, 2020

Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment

Journal of Alzheimer's Disease : JAD
Antoine R TrammellIhab M Hajjar
August 6, 2020
Open Access

COX5A Plays a Vital Role in Memory Impairment Associated With Brain Aging via the BDNF/ERK1/2 Signaling Pathway

Frontiers in Aging Neuroscience
Yan-Bin XiyangJie Zhang
August 5, 2020

The influence of age of acquisition on recall and recognition in Alzheimer's patients and healthy ageing controls in Turkish

Applied Neuropsychology. Adult
Elçin KilecioğluEvren Raman
August 6, 2020

Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Kwangsik NhoAlzheimer's Disease Neuroimaging Initiative

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-early-markers/3f21ed1f-09e4-44f3-b22b-8e0c54be37b6